REGISTRY SNAPSHOT: Israeli Clinical Trials Department

by Staff writer,
Posted on 4/16/2019

Knowing which countries to submit clinical trial results summaries to is the easy part. What becomes difficult is learning the intricacies and transparency requirements of every clinical trial registry globally, including the Israeli Clinical Trials Department. Here is an overview of this registry:

Registry name: Israeli Clinical Trials Department

Country: Israel

Points of interest:

  • The Clinical Trials Department is part of Israel’s Ministry of Health
  • The country of Israel does not operate its own clinical trials registry, rather, it reports clinical trial results to ClinicalTrials.gov.
  • The Israeli Clinical Trials Department approves and supervises clinical trials involving human subjects
  •  In Israel, clinical trials are defined as:
    • Special: a trial conveyed for final approval to the director of the hospital
    • Non-special: a trial that requires additional approval of the Director
  • Genetic studies are conducted in accordance with the Genetic Information Law of 2000
  • Only physicians licensed in Israel may apply for permission to perform clinical trials
  • Any clinical trials with human subjects must comply with the Public Health Regulations of 1980

Related transparency research/articles:

TrialAssure® Registry can automate the disclosure of clinical trial results for the Israeli Clinical Trials Department. For questions or a free demo, fill out this form.

Share: